Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas G Bader

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Cell Cycle (Georgetown, Tex.)|January 25, 2014
miR-888: hit it when you see it!Andreas G Bader
Frontiers in Genetics|July 12, 2012
miR-34 - a microRNA replacement therapy is headed to the clinicAndreas G Bader
Methods in Molecular Biology (Clifton, N.J.)|June 15, 2015
A qRT-PCR Method for Determining the Biodistribution Profile of a miR-34a MimicKevin Kelnar, Andreas G Bader
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2016
Evaluating Synergistic Effects of miR-34a Mimics in Combination with Other Therapeutic Agents in Cultured Non-Small Cell Lung Cancer CellsJane Zhao, Andreas G Bader
Oncogene|April 20, 2004
An essential role for protein synthesis in oncogenic cellular transformationAndreas G Bader, Peter K Vogt
Molecular Cell|August 20, 2005
Jun: stealth, stability, and transformationPeter K Vogt, Andreas G Bader
Molecular and Cellular Biology|March 4, 2005
Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformationAndreas G Bader, Peter K Vogt
Cancer Research|September 3, 2010
The promise of microRNA replacement therapyAndreas G Bader, David Brown, Matthew Winkler
Plos One|February 20, 2014
In-depth analysis shows synergy between erlotinib and miR-34aJane Zhao, Kevin Kelnar, Andreas G Bader
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
Cancer-specific mutations in PIK3CA are oncogenic in vivoAndreas G Bader, Sohye Kang, Peter K Vogt
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|January 25, 2014
miR-888: hit it when you see it!Andreas G Bader
Frontiers in Genetics|July 12, 2012
miR-34 - a microRNA replacement therapy is headed to the clinicAndreas G Bader
Methods in Molecular Biology (Clifton, N.J.)|June 15, 2015
A qRT-PCR Method for Determining the Biodistribution Profile of a miR-34a MimicKevin Kelnar, Andreas G Bader
Methods in Molecular Biology (Clifton, N.J.)|December 8, 2016
Evaluating Synergistic Effects of miR-34a Mimics in Combination with Other Therapeutic Agents in Cultured Non-Small Cell Lung Cancer CellsJane Zhao, Andreas G Bader
Oncogene|April 20, 2004
An essential role for protein synthesis in oncogenic cellular transformationAndreas G Bader, Peter K Vogt
Molecular Cell|August 20, 2005
Jun: stealth, stability, and transformationPeter K Vogt, Andreas G Bader
Molecular and Cellular Biology|March 4, 2005
Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformationAndreas G Bader, Peter K Vogt
Cancer Research|September 3, 2010
The promise of microRNA replacement therapyAndreas G Bader, David Brown, Matthew Winkler
Plos One|February 20, 2014
In-depth analysis shows synergy between erlotinib and miR-34aJane Zhao, Kevin Kelnar, Andreas G Bader
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
Cancer-specific mutations in PIK3CA are oncogenic in vivoAndreas G Bader, Sohye Kang, Peter K Vogt
Pageof 4